Latest hepatitis C Stories
MarketOptimizer.org adds “PharmaPoint: Hepatitis C Virus – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store.
Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens WOONSOCKET, R.I., Sept.
Complimentary Hayes, Inc.
PITTSBURGH and HYDERABAD, India, Sept. 15, 2014 /PRNewswire/ -- Mylan Inc.
NEW YORK, Sept.
Genomics R&D firm, Ryogen LLC, has been awarded two U.S.
Dr. Joseph Boscarino's research into disease that claimed his brother a major breakthrough DANVILLE, Pa., Aug.
Reimbursement and Out-of-Pocket Costs are the Leading Reasons for Treatment Discontinuation, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
Newly implemented screening guidelines and improved, highly effective drug therapies could make hepatitis C a rare disease in the United States by 2036.
Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...